Related Experiment Video
Updated: Aug 7, 2026
07:37
An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
Cyclooxygenase-2 genotype and rheumatoid arthritis
Kyu Hoon Lee1, Hee-Sang Kim, Ahmed El-Sohemy
1Department of Physical Medicine and Rehabilitation, Division of Rheumatology, and the Hospital for Rheumatic Diseases, Hanyang University, Seoul, Korea.
The Journal of Rheumatology
|July 6, 2006
Summary
Cyclooxygenase-2 (COX-2) genotyping showed no direct link to rheumatoid arthritis (RA) risk or severity in Koreans. However, in individuals without the shared epitope (SE), specific COX-2 genotypes may predict lower RA risk and milder disease.
Area of Science:
- Genetics
- Immunology
- Rheumatology
Background:
- Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by joint inflammation and potential damage.
- Genetic factors, including variations in cyclooxygenase-2 (COX-2) and the shared epitope (SE), are implicated in RA pathogenesis.
- Understanding these genetic associations can aid in predicting disease risk and severity.
Purpose of the Study:
- To investigate the association between cyclooxygenase-2 (COX-2) gene polymorphisms and the risk and severity of rheumatoid arthritis (RA) in a Korean population.
- To explore potential interactions between COX-2 genotypes and the shared epitope (SE) in influencing RA outcomes.
Main Methods:
- A case-control study involving 258 Korean RA patients and 400 healthy controls.
- Genotyping of the COX-2 -765G/C polymorphism using RFLP-PCR.
- Assessment of RA risk using odds ratios (OR) and 95% confidence intervals (CI).
- Evaluation of RA severity based on the Steinbrocker anatomical staging system.
Main Results:
- No significant association was found between COX-2 genotypes and overall RA risk or severity.
- In patients lacking the shared epitope (SE), carriers of the low-activity COX-2 C allele exhibited a significantly lower risk of developing RA (OR = 0.36; 95% CI = 0.14-0.95).
- Similarly, among SE-negative individuals, the COX-2 C allele was associated with less severe RA (OR = 0.04; 95% CI = 0.01-0.41).
Conclusions:
- COX-2 genotyping may serve as a predictive tool for RA risk and severity, particularly in individuals without the shared epitope (SE).
- These findings highlight the complex interplay between different genetic factors in rheumatoid arthritis.
- Further research is warranted to validate these associations and explore therapeutic implications.
Related Concept Videos
01:11Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
01:23Rheumatic Heart Disease I: Introduction
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...